Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.7B | $14.2B | $14.6B | $14.9B | $15.5B | |
| Revenue Growth (YoY) | 19.88% | 11.58% | 2.47% | 2.25% | 4.31% | |
| Cost of Revenues | $8.5B | $9.6B | $9.7B | $9.9B | $10.4B | |
| Gross Profit | $4.2B | $4.6B | $4.8B | $4.9B | $5.2B | |
| Gross Profit Margin | 33.05% | 32.59% | 33.22% | 33.26% | 33.24% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.9B | $3.2B | $3.4B | $3.5B | $3.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.8B | $3.2B | $3.4B | $3.5B | $3.7B | |
| Operating Income | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Net Interest Expenses | $26.6M | $30.6M | $46.5M | $54.6M | $69.1M | |
| EBT. Incl. Unusual Items | $1.3B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $283M | $315.6M | $325.2M | $311.7M | $302.2M | |
| Net Income to Company | $997.1M | $1.1B | $1.1B | $1.1B | $1.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $997.1M | $1.1B | $1.1B | $1.1B | $1.1B | |
| Basic EPS (Cont. Ops) | $1.74 | $1.96 | $2.03 | $2.05 | $2.07 | |
| Diluted EPS (Cont. Ops) | $1.72 | $1.94 | $2.02 | $2.04 | $2.06 | |
| Weighted Average Basic Share | $574M | $556.7M | $545.5M | $536.9M | $530M | |
| Weighted Average Diluted Share | $579.1M | $560.7M | $548.7M | $539.7M | $532.2M | |
| EBITDA | $1.6B | $1.8B | $1.9B | $1.9B | $2B | |
| EBIT | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Revenue (Reported) | $12.7B | $14.2B | $14.6B | $14.9B | $15.5B | |
| Operating Income (Reported) | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Operating Income (Adjusted) | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $4B | $3.7B | $3.8B | $3.9B | |
| Revenue Growth (YoY) | 15.32% | 20.7% | -8.65% | 3.11% | 3.31% | |
| Cost of Revenues | $2.3B | $2.7B | $2.5B | $2.6B | $2.7B | |
| Gross Profit | $1B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Gross Profit Margin | 31.49% | 31.67% | 32.51% | 32.05% | 31.86% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $752.1M | $909.6M | $855.6M | $891.2M | $944.4M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $741.4M | $909.6M | $855.6M | $891.2M | $944.4M | |
| Operating Income | $303.8M | $359.2M | $334.2M | $318.3M | $297.7M | |
| Net Interest Expenses | $6.5M | $10.2M | $11.9M | $17.2M | $16.9M | |
| EBT. Incl. Unusual Items | $286.5M | $349M | $322.3M | $301.1M | $280.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $65.2M | $78.1M | $74.4M | $64.7M | $53.5M | |
| Net Income to Company | $221.3M | $270.9M | $247.9M | $236.4M | $227.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $221.3M | $270.9M | $247.9M | $236.4M | $227.4M | |
| Basic EPS (Cont. Ops) | $0.39 | $0.49 | $0.46 | $0.44 | $0.43 | |
| Diluted EPS (Cont. Ops) | $0.39 | $0.49 | $0.46 | $0.44 | $0.43 | |
| Weighted Average Basic Share | $568.3M | $552.2M | $540.7M | $533.6M | $528M | |
| Weighted Average Diluted Share | $573.9M | $556.4M | $544.1M | $536.4M | $530.3M | |
| EBITDA | $379.2M | $454M | $437.5M | $438.4M | $425.5M | |
| EBIT | $303.8M | $359.2M | $334.2M | $318.3M | $297.7M | |
| Revenue (Reported) | $3.3B | $4B | $3.7B | $3.8B | $3.9B | |
| Operating Income (Reported) | $303.8M | $359.2M | $334.2M | $318.3M | $297.7M | |
| Operating Income (Adjusted) | $303.8M | $359.2M | $334.2M | $318.3M | $297.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $12.7B | $14.2B | $14.6B | $14.9B | $15.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8.5B | $9.6B | $9.7B | $9.9B | $10.4B | |
| Gross Profit | $4.2B | $4.6B | $4.8B | $4.9B | $5.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.9B | $3.2B | $3.4B | $3.5B | $3.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.8B | $3.2B | $3.4B | $3.5B | $3.7B | |
| Operating Income | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Net Interest Expenses | $26.6M | $30.6M | $46.5M | $54.6M | $69.1M | |
| EBT. Incl. Unusual Items | $1.3B | $1.4B | $1.4B | $1.4B | $1.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $283M | $315.6M | $325.2M | $311.7M | $302.2M | |
| Net Income to Company | $997.1M | $1.1B | $1.1B | $1.1B | $1.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $997.1M | $1.1B | $1.1B | $1.1B | $1.1B | |
| Basic EPS (Cont. Ops) | $1.74 | $1.96 | $2.03 | $2.05 | $2.07 | |
| Diluted EPS (Cont. Ops) | $1.72 | $1.94 | $2.02 | $2.04 | $2.06 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.6B | $1.8B | $1.9B | $1.9B | $2B | |
| EBIT | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Revenue (Reported) | $12.7B | $14.2B | $14.6B | $14.9B | $15.5B | |
| Operating Income (Reported) | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Operating Income (Adjusted) | $1.4B | $1.4B | $1.5B | $1.5B | $1.5B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $14.2B | $14.6B | $14.9B | $15.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.6B | $9.7B | $9.9B | $10.4B | -- | |
| Gross Profit | $4.6B | $4.8B | $4.9B | $5.2B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.2B | $3.4B | $3.5B | $3.7B | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $3.2B | $3.4B | $3.5B | $3.7B | -- | |
| Operating Income | $1.4B | $1.5B | $1.5B | $1.5B | -- | |
| Net Interest Expenses | $30.6M | $46.5M | $54.6M | $69.1M | -- | |
| EBT. Incl. Unusual Items | $1.4B | $1.4B | $1.4B | $1.4B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $315.6M | $325.2M | $311.7M | $302.2M | -- | |
| Net Income to Company | $1.1B | $1.1B | $1.1B | $1.1B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1B | $1.1B | $1.1B | $1.1B | -- | |
| Basic EPS (Cont. Ops) | $1.96 | $2.03 | $2.05 | $2.07 | -- | |
| Diluted EPS (Cont. Ops) | $1.94 | $2.02 | $2.04 | $2.06 | -- | |
| Weighted Average Basic Share | $2.2B | $2.2B | $2.1B | $2.1B | -- | |
| Weighted Average Diluted Share | $2.2B | $2.2B | $2.2B | $2.1B | -- | |
| EBITDA | $1.8B | $1.9B | $1.9B | $2B | -- | |
| EBIT | $1.4B | $1.5B | $1.5B | $1.5B | -- | |
| Revenue (Reported) | $14.2B | $14.6B | $14.9B | $15.5B | -- | |
| Operating Income (Reported) | $1.4B | $1.5B | $1.5B | $1.5B | -- | |
| Operating Income (Adjusted) | $1.4B | $1.5B | $1.5B | $1.5B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $878M | $202.5M | $397.1M | $251.5M | $194.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $2.2B | $2.7B | $2.6B | $2.8B | $3.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $164.1M | $245.7M | $218.6M | $196.6M | -- | |
| Total Current Assets | $3.3B | $3.2B | $3.3B | $3.3B | $3.5B | |
| Property Plant And Equipment | $4.4B | $5B | $5.6B | $6.1B | $7B | |
| Long-Term Investments | $14.9M | $18.4M | $25.2M | $26.2M | -- | |
| Goodwill | $32.4M | $230.2M | $246.4M | $246.4M | -- | |
| Other Intangibles | $23.1M | $23.1M | $23.1M | $23.1M | -- | |
| Other Long-Term Assets | $55.4M | $41.5M | $75.5M | $83.2M | -- | |
| Total Assets | $8.6B | $9.4B | $9.2B | $9.8B | $10.9B | |
| Accounts Payable | $1.2B | $1.4B | $1.2B | $1.2B | $1.4B | |
| Accrued Expenses | $474.4M | $498.6M | $533M | $582M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $325.2M | $349.6M | $372.8M | $400.2M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.1B | $2.4B | $2.2B | $2.3B | $2.6B | |
| Long-Term Debt | $3.6B | $3.9B | $4.7B | $5B | $5.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.6B | $7.4B | $7B | $7.5B | $8.4B | |
| Common Stock | $1.4M | $1.4M | $1.4M | $7.1M | $7.1M | |
| Other Common Equity Adj | $1.3M | $11.3M | $6.8M | $1.2M | -- | |
| Common Equity | $2B | $2B | $2.1B | $2.3B | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2B | $2B | $2.1B | $2.3B | $2.6B | |
| Total Liabilities and Equity | $8.6B | $9.4B | $9.2B | $9.8B | $10.9B | |
| Cash and Short Terms | $878M | $202.5M | $397.1M | $251.5M | $194.1M | |
| Total Debt | $3.6B | $3.9B | $4.7B | $5B | $5.5B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $878M | $202.5M | $397.1M | $251.5M | $194.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $2.2B | $2.7B | $2.6B | $2.8B | $3.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $164.1M | $245.7M | $218.6M | $196.6M | -- | |
| Total Current Assets | $3.3B | $3.2B | $3.3B | $3.3B | $3.5B | |
| Property Plant And Equipment | $4.4B | $5B | $5.6B | $6.1B | $7B | |
| Long-Term Investments | $14.9M | $18.4M | $25.2M | $26.2M | -- | |
| Goodwill | $32.4M | $230.2M | $246.4M | $246.4M | -- | |
| Other Intangibles | $23.1M | $23.1M | $23.1M | $23.1M | -- | |
| Other Long-Term Assets | $55.4M | $41.5M | $75.5M | $83.2M | -- | |
| Total Assets | $8.6B | $9.4B | $9.2B | $9.8B | $10.9B | |
| Accounts Payable | $1.2B | $1.4B | $1.2B | $1.2B | $1.4B | |
| Accrued Expenses | $474.4M | $498.6M | $533M | $582M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $325.2M | $349.6M | $372.8M | $400.2M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.1B | $2.4B | $2.2B | $2.3B | $2.6B | |
| Long-Term Debt | $3.6B | $3.9B | $4.7B | $5B | $5.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.6B | $7.4B | $7B | $7.5B | $8.4B | |
| Common Stock | $1.4M | $1.4M | $1.4M | $7.1M | $7.1M | |
| Other Common Equity Adj | $1.3M | $11.3M | $6.8M | $1.2M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $2B | $2B | $2.1B | $2.3B | $2.6B | |
| Total Liabilities and Equity | $8.6B | $9.4B | $9.2B | $9.8B | $10.9B | |
| Cash and Short Terms | $878M | $202.5M | $397.1M | $251.5M | $194.1M | |
| Total Debt | $3.6B | $3.9B | $4.7B | $5B | $5.5B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $997.1M | $1.1B | $1.1B | $1.1B | $1.1B | |
| Depreciation & Amoritzation | $270.2M | $343.1M | $393M | $447.2M | $494M | |
| Stock-Based Compensation | $47.6M | $53.8M | $57M | $48.4M | $57.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$407.9M | -$349.7M | $40.9M | -$194.3M | -$225.7M | |
| Cash From Operations | $1.1B | $1.4B | $1.3B | $1.4B | $1.6B | |
| Capital Expenditures | $628.4M | $773.4M | $753.9M | $784M | $894.8M | |
| Cash Acquisitions | -- | $390.8M | -- | -- | $139.9M | |
| Cash From Investing | -$627.3M | -$1.1B | -$653.1M | -$643.9M | -$778.6M | |
| Dividends Paid (Ex Special Dividend) | $239M | $409.6M | $449.6M | $472.5M | $487.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1B | $1.8B | $785M | -- | |
| Long-Term Debt Repaid | -$4.6M | -$836.1M | -$1.2B | -$689.8M | -- | |
| Repurchase of Common Stock | $813.8M | $728.7M | $618.6M | $584.6M | $377.1M | |
| Other Financing Activities | -- | -- | -$9.7M | -- | -- | |
| Cash From Financing | -$975.1M | -$938.8M | -$486.4M | -$922.5M | -$914.1M | |
| Beginning Cash (CF) | $878M | $202.5M | $397.1M | $251.5M | $194.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$463.7M | -$675.5M | $194.6M | -$145.6M | -$57.4M | |
| Ending Cash (CF) | $414.3M | -$473M | $591.6M | $105.9M | $136.7M | |
| Levered Free Cash Flow | $510.3M | $583.6M | $580.2M | $636.8M | $740.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $221.3M | $270.9M | $247.9M | $236.4M | $227.4M | |
| Depreciation & Amoritzation | $75.4M | $94.8M | $103.3M | $120.1M | $127.8M | |
| Stock-Based Compensation | $11.9M | $15.3M | $11.9M | $13.2M | $15.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | $8.6M | $137.3M | $188.4M | $242.3M | $168.7M | |
| Cash From Operations | $266.9M | $730.6M | $396.1M | $517.2M | $324.8M | |
| Capital Expenditures | $246.1M | $322.2M | $227.2M | $246M | $265.6M | |
| Cash Acquisitions | -- | $390.8M | -- | -- | -- | |
| Cash From Investing | -$246.1M | -$642.7M | -$198.5M | -$183.8M | -$101.7M | |
| Dividends Paid (Ex Special Dividend) | $59.2M | $101.7M | $111.4M | $117.3M | $121.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $890M | -- | $200M | -- | |
| Long-Term Debt Repaid | -$1.2M | -$802.8M | -$1.2M | -$203.5M | -- | |
| Repurchase of Common Stock | $201.2M | $92.3M | $114.2M | $154.3M | $117.4M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$254.5M | -$96.6M | -$222.3M | -$268.2M | -$213.7M | |
| Beginning Cash (CF) | $878M | $202.5M | $397.1M | $251.5M | $194.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$233.7M | -$8.7M | -$24.6M | $65.2M | $9.5M | |
| Ending Cash (CF) | $644.3M | $193.8M | $372.4M | $316.7M | $203.6M | |
| Levered Free Cash Flow | $20.8M | $408.4M | $168.9M | $271.2M | $59.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $997.1M | $1.1B | $1.1B | $1.1B | $1.1B | |
| Depreciation & Amoritzation | $270.2M | $343.1M | $393M | $447.2M | $494M | |
| Stock-Based Compensation | $47.6M | $53.8M | $57M | $48.4M | $57.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$407.9M | -$349.7M | $40.9M | -$194.3M | -$225.7M | |
| Cash From Operations | $1.1B | $1.4B | $1.3B | $1.4B | $1.6B | |
| Capital Expenditures | $628.4M | $773.4M | $753.9M | $784M | $894.8M | |
| Cash Acquisitions | -- | $390.8M | -- | -- | $139.9M | |
| Cash From Investing | -$627.3M | -$1.1B | -$653.1M | -$643.9M | -$778.6M | |
| Dividends Paid (Ex Special Dividend) | $239M | $409.6M | $449.6M | $472.5M | $487.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1B | $1.8B | $785M | -- | |
| Long-Term Debt Repaid | -$4.6M | -$836.1M | -$1.2B | -$689.8M | -- | |
| Repurchase of Common Stock | $813.8M | $728.7M | $618.6M | $584.6M | $377.1M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$975.1M | -$938.8M | -$486.4M | -$922.5M | -$914.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$463.7M | -$675.5M | $194.6M | -$145.6M | -$57.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $510.3M | $583.6M | $580.2M | $636.8M | $740.5M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $1.1B | $1.1B | $1.1B | -- | |
| Depreciation & Amoritzation | $343.1M | $393M | $447.2M | $494M | -- | |
| Stock-Based Compensation | $53.8M | $57M | $48.4M | $57.1M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$349.7M | $40.9M | -$194.3M | -$225.7M | -- | |
| Cash From Operations | $1.4B | $1.3B | $1.4B | $1.6B | -- | |
| Capital Expenditures | $773.4M | $753.9M | $784M | $894.8M | -- | |
| Cash Acquisitions | $390.8M | -- | -- | $139.9M | -- | |
| Cash From Investing | -$1.1B | -$653.1M | -$643.9M | -$778.6M | -- | |
| Dividends Paid (Ex Special Dividend) | $409.6M | $449.6M | $472.5M | $487.7M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1B | $1.8B | $785M | $1.3B | -- | |
| Long-Term Debt Repaid | -$836.1M | -$1.2B | -$689.8M | -$1.5B | -- | |
| Repurchase of Common Stock | $728.7M | $618.6M | $584.6M | $377.1M | -- | |
| Other Financing Activities | -- | -$9.7M | -- | -- | -- | |
| Cash From Financing | -$938.8M | -$486.4M | -$922.5M | -$914.1M | -- | |
| Beginning Cash (CF) | $1.3B | $1.6B | $1.1B | $836.3M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$675.5M | $194.6M | -$145.6M | -$57.4M | -- | |
| Ending Cash (CF) | $674.5M | $1.8B | $951M | $778.9M | -- | |
| Levered Free Cash Flow | $583.6M | $580.2M | $636.8M | $740.5M | -- | |
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.